A detailed history of Geneos Wealth Management Inc. transactions in Glaukos Corp stock. As of the latest transaction made, Geneos Wealth Management Inc. holds 12 shares of GKOS stock, worth $1,663. This represents 0.0% of its overall portfolio holdings.

Number of Shares
12
Holding current value
$1,663
% of portfolio
0.0%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$113.62 - $135.39 $1,363 - $1,624
12 New
12 $1,000
Q1 2018

Sep 07, 2021

SELL
$26.05 - $34.5 $46,447 - $61,513
-1,783 Closed
0 $0
Q4 2017

Sep 07, 2021

BUY
$24.5 - $36.01 $23,961 - $35,217
978 Added 121.49%
1,783 $45,000
Q3 2017

Sep 07, 2021

SELL
$31.26 - $42.03 $16,724 - $22,486
-535 Reduced 39.93%
805 $26,000
Q2 2017

Sep 07, 2021

BUY
N/A
1,340 New
1,340 $55,000
Q1 2017

Sep 07, 2021

SELL
N/A
-3,635 Closed
0 $0
Q1 2016

Sep 07, 2021

BUY
N/A
3,635
3,635 $62,000

Others Institutions Holding GKOS

About GLAUKOS Corp


  • Ticker GKOS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 47,596,900
  • Market Cap $6.6B
  • Description
  • Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...
More about GKOS
Track This Portfolio

Track Geneos Wealth Management Inc. Portfolio

Follow Geneos Wealth Management Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Geneos Wealth Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Geneos Wealth Management Inc. with notifications on news.